×
For best experience we recommend to activate Javascript in your browser.
Recombinant TNFSF13 (Sibeprenlimab Biosimilar) antibody
This Human Monoclonal antibody specifically detects TNFSF13 (Sibeprenlimab Biosimilar) in BLI, ELISA, FACS, Func and SPR. It exhibits reactivity toward Human.
Catalog No. ABIN7676110
$294.23
$346.15
save $51.92 (-15 %)
Plus shipping costs $50.00
1 mg ABIN7581729
100 μg ABIN7676110
1 mg ABIN7581729
100 μg ABIN7676110
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant TNFSF13 (Sibeprenlimab Biosimilar) antibody (ABIN7676110)
Target
TNFSF13 (Sibeprenlimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for TNFSF13 (Sibeprenlimab Biosimilar) antibodies
Human
Clonality
All clonalities for TNFSF13 (Sibeprenlimab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for TNFSF13 (Sibeprenlimab Biosimilar) antibodies
This TNFSF13 (Sibeprenlimab Biosimilar) antibody is un-conjugated
Application
Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
Product Details anti-TNFSF13 (Sibeprenlimab Biosimilar) Antibody
(hide)
Expression System
CHO Cells
Purpose
Anti-TNFSF13 / APRIL / CD256 Reference Antibody (sibeprenlimab)
Characteristics
Anti-TNFSF13 / APRIL / CD256 Reference Antibody (sibeprenlimab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG2SA
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for TNFSF13 (Sibeprenlimab Biosimilar)
(hide)
Target
TNFSF13 (Sibeprenlimab Biosimilar)
Target Type
Biosimilar
Molecular Weight
145.5 kDa
UniProt
O75888
Recently viewed
(hide)
Chat with us , powered by LiveChat